about us

The Dyadic Netherlands team consists of 17 scientists and researchers with a strong background in molecular biology, microbiology, biochemistry and fermentation technology.

We develop industrial enzymes for applications in the production of:

• Biofuels
• Biochemicals
• Textile
• Paper and Pulp
• Starch
• Feed
• Food

In addition, Dyadic has proprietary technologies to advance the discovery and production of therapeutic proteins, e.g., monoclonal antibodies.

Dyadic Netherlands, is a fully-owned subsidiary of Dyadic International Inc., having its headquarters in Jupiter (Florida, USA).

Our technology is based on its proprietary fungal Myceliophthora thermophila C1-expression system, protected by a number of patents. The unique morphology, the high expression levels and the limited nutritional needs of the fungus allow high production levels at low costs.

Dyadic Netherlands offers third parties access to its technology through contract research and licenses. The technology to produce enzymes for biofuel production is outlicensed on a non-exclusive basis to Codexis (partner of Royal Dutch Shell) and Abengoa Bioenergy, the largest producer of bioethanol in Europe.

Dyadic Netherlands is involved in a number of national and European projects.